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Previous evidence demonstrated that drug­induced extracellular dopamine (DA) concentrations 
in the nucl. accumbens shell (AcbSh) might underlie different vulnerabilities to heroin 
addiction in inbred mice strains. We investigated a potential role of the responsiveness of the 
DA system in the AcbSh with respect to the vulnerability to heroin­influenced conditioned 
place preference (CPP) in rats. Animals were randomly assigned to the heroin and saline 
(control) groups. Heroin­group rats were then re­classified into two groups according to the 
degree of heroin­induced CPP, high preference (HP) and low­preference (LP) ones. The le vels 
of extracellular DA and dihydroxyphenyl acetic acid (DOPAC) were estimated dyna mically 
by in vivo microdialysis. Compared with the saline group, extracellular DA and DOPAC 
concentrations in the heroin­treated groups were significantly higher 30 min after the last 
injection, but the DA level decreased sharply in these groups on days 1 and 3 and became 
lower than that of the saline group. Compared with LP­group rats, HP­rats displayed a higher 
heroin­induced increase in the DA concentration 30 min after the last heroin injection and 
higher DOPAC and DOPAC/DA ratios 14 days after such injection. These results suggest 
that differences in the DA system responsiveness in the AcbSh may determine individual 
differences in vulnerability to heroin addiction. 
Keywords: nucl. accumbens shell, heroin addiction, vulnerability, dopamine, conditioned 
place preference (CPP).
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INTRODUCTION 
Individual vulnerability to the reinforcing effects of 
drugs appears to be a crucial factor in the development 
of addictions in humans. The mesolimbic dopamine 
(DA) system has been implicated as an important 
substrate for reinforcing effects of most drugs of abuse 
[1] (like opioids, including heroin). The rewarding 
effects of addictive drugs are thought to be mediated 
by increased DA­ergic transmission in the projections 
originating from the ventral tegmental area (VTA) that 
innervate the nucl. accumbens (Acb) and prefrontal 
cortex [2, 3]. 
Two subregions of the Acb, the dorsolateral core 
and the ventromedial shell, are thought to subserve 
different functions related to the reinforcing properties 
of drug rewards. Some studies suggest that the Acb 
shell (AcbSh) plays an important role in the reward 
function of DA [4]. Rats can learn self­administration 
by perfusing DA uptake inhibitors (nomifensine [5] and 
cocaine [6]) and also mixtures of D1 and D2 receptor 
agonists [7] into the shell but not the core of the 
above nucleus. In addition, systemic D­amphetamine­
influenced conditioned place preference (CPP), a 
measure of reward, can be attenuated by selective 
lesions of DA­ergic terminals in the AcbSh but not in 
the core of this structure [8].
The link between DA­ergic functioning and 
behavioral processes has been extensively studied 
in the field of drug abuse [9]. The results allowed 
researchers to suggest that individual differences in 
the DA­ergic function can result in varying degrees of 
susceptibility to drug abuse [10]. 
In animal studies, it has been argued that the 
intrinsic properties of drugs of abuse do not account 
per se for individual variability in the occurrence 
of drug addiction, and different extracellular DA 
concentrations in the AcbSh may underlie the above 
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specificities [11]. Thus, individual differences in 
the responsiveness of the DA system to novelty and 
stress have been shown to predict the susceptibility of 
individual animals to drug addiction [12]. According 
to this hypothesis, individuals with a hyperresponsive 
DA system would be more prone to drug addiction. 
Furthermore, this difference in individual vulnerability 
to addiction may be based on neural substrates and 
genetic background [11]. 
Previous studies of addiction susceptibili ty 
differences focused on different rat strains. Among 
such different strains, dissimilar susceptibility to 
addictive drugs, in particular amphetamine [13], 
cocaine [14], alcohol [15], and opioids [16], has been 
found, and the vulnerability difference was interrelated 
with drug­induced changes in the DA concentrations. 
Some studies seem to suggest that highly­vulnerable 
animals have a higher basal DOPAC/DA ratio in the 
Acb and higher extracellular concentrations of DA in 
this structure in response to the action of addictive 
drugs [17, 18]. 
Conditioned place preference (CPP) is an evaluation 
measure of the rewarding effect [19]. Rats of different 
strains showed different intensities of drug­induced 
CPP, and it was suggested that genetic differences 
may underlie dissimilar sensitivities to the place­
conditioning procedure [20]. However, different CPP 
dynamics can be seen in the same rat strains, which is 
related to the response to novel environment. Animals 
with high responses to novel environment tend to 
have higher scores of the CPP development [21]. 
Nevertheless, it is not clear whether differences in the 
CPP development and responses to novel environment 
are also related to the DA responsiveness in the AcbSh 
of rats of the same strain. Furthermore, there is a lack 
of studies on the dynamic variety of extracellular DA 
concentrations and DA update rate in the AcbSh the 
same­strain rats, especially with respect to heroin 
addiction. 
In our study, we used brain microdialysis in freely 
moving rats to examine the effect of heroin on changes 
in the extracellular DA and DOPAC concentrations in 
the AcbSh between same­strain rats demonstrating 
different vulnerability within the addiction and 
withdrawal phases of the respective experiment.
METHODS
Animals. Male Sprague–Dawley rats (n = 48, body 
mass 250 to 300 g) were obtained from the Animal 
Center of the Xiangya Medical College, Central South 
University. They were housed in standard breeding 
cages (27×21×13.5 cm) maintained at 20­25°C, 
relative humidity 55%, with an automatic 12­h light/
dark cycle. (8 a.m. to 8 p.m.). All rats were allowed to 
acclimatize for one week before the experiment.
Behavioral Tests. In the CPP experiments, there 
were four identical two­chamber Plexiglas boxes 
with two equal­size compartments (30×30×30 cm). 
One compartment was painted white and had a mesh 
floor, while the other compartment was painted black 
and had a smooth floor. Two replaceable clapboards 
with white­black sides were used to separate the 
compartments. One replaced clapboard contained a 
10 × 10 cm opening that allowed free access to the two 
compartments.
The rats were randomly assigned into heroin­
treated and control (saline) groups (n = 40 and n = 
= 8, respectively). The apparatus was located in a room 
separate from the colony room, which was supplied 
with white noise (ambient background of 70 dB) in 
order to mask extraneous sounds. A video camera and 
a remote computer monitor allowed us to measure time 
intervals spent by rats in the compartments of the CPP 
apparatus. 
The pre­conditioning phase was 3 day long. Every 
day, all rats were placed into the CPP apparatus for 
30 min with the replaced clapboard. On the 2nd and 
3rd days, the time the rats spent in each compartment 
was recorded for 15 min, with each entry and exit 
being defined as both front paws in the respective 
compartment. The average of the two times was 
considered the baseline CPP (Pre). Then heroin was 
paired with the nonpreferred compartment, and another 
side was paired with saline injection. The conditioning 
phase was 7 days, and the heroin­group rats were 
subjected to a randomly balanced order of conditioning 
in which either heroin or saline was first or repeated. 
Everyday conditioning training was conducted with 
twice heroin and twice equal­volume saline injections, 
respectively. Every time the rats were injected with 
saline or heroin, they were then placed immediately 
for 30 min into the paired compartment. The time 
interval between two trains was not shorter than 4 h. 
Heroin was administered according to an escalating 
dose schedule. Doses within 7 days increased from 
0.5 mg/kg on day 1 to 3.5 mg/kg bid i.h. on day 7. Saline­
group rats were injected only with an equal volume of 
saline and subjected to the same CPP procedure. 
On the next after the last conditioning day, each rat 
was subjected to a preference test in a drug­free state. 
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The rat was placed within the middle opening of the 
replaced clapboard to allow free access of the animal 
to the entire apparatus for 15 min. Total times spent in 
the white and black compartments were measured. The 
difference (sec) between the time spent in the drug­
paired compartment within the testing phase and the 
preconditioning phase was considered a measure of 
the degree of heroin­induced conditioning. The drug­
influenced preference was taken into account if the 
difference was positive.
When the CPP testing phase was terminated, 
animals of the studied groups were reclassified into 
two groups according to the degree of heroin­induced 
conditioning. These were the high­preference group 
(HP, n = 12) and the low preference group (LP, n = 
= 12); each group included 30% of the total number 
of animals examined. The HP­ and LP­group rats 
were injected with heroin (3.5 mg/kg bid i.h) until 
microdialysis sample collection was started.
Microdialysis Procedures. Brain microdialysis 
experiments were performed as was previously 
described. Rats were stereotaxically implanted under 
4% pentobarbital sodium (30­35 mg/kg) anesthesia 
with a CMA/11 guide cannula. This cannula was fixed 
in position with three stainless steel screws and dental 
acrylic plastic with its tip close to the AcbSh (FP 
1.7 mm, ML 0.7 mm; and DV 7.0 mm from the 
bregma). A dummy probe was then inserted into the 
guide cannula to prevent obstruction. 
After recovery from surgery (48 h), the rats were 
connected to a microperfusion pump (CMA/110; 
CMA/Microdialysis AB, Sweden) and placed into 
a cylindrical Plexiglas transparent microdialysis 
container (30 cm in diameter; 35 cm in height), 
where they were allowed to move freely. The dummy 
probe was replaced with a concentric microdialysis 
probe (CMA/11, CMA/Microdialysis AB, Sweden; 
membrane, 1.0 mm; cut­off, 6000 Dalton; shaft 
length, 14 mm). They were inserted through the guide 
cannula, extending beyond the cannula tip to maximize 
the contact of the dialysis membrane­exposed surface 
area with the AcbSh. 
Ringer solution (140 mM NaCl, 1.2 mM CaCl
2
, 
3.0 mM KCl, and 1.0 mM MgCl
2
) was perfused 
through the syringe pump connected to the probe via a 
fluorinated ethylene­propylene tubing (FEP, 0.005″ ID) 
at a flow rate of 2.0 μl/min for at least 90 min prior to 
the start of sample collections. Samples were collected 
30 min and on days 1, 3, 7, and 14 after the last heroin 
injection into refrigerated (4°C) microcentrifuge tubes 
containing 2.0 µl of hydrochloric acid to prevent 
enzymatic breakdown.
Analyses of the dialysate samples were performed 
by high­performance liquid chromatography with 
a coulometric electrode array system (HPLC­EC 
CoulArrar5600A; ESA, USA). A standard curve was 
plotted according to 100, 50, 20, 10, 1, 0.5, and 0.05 
µg/l dopamine standards (Sigma, USA). Correlation 
coefficients (r2) for the peak area of concentrations 
of the standard curve were calculated using linear 
regression. The results showed that the standard linear 
curve had satisfactory r2 values (DA: y = 16.157 x, 
r2 = 0.9998, and DOPAC: y = 16.619 x, r2 = 0.9992). 
An output from the detector was analyzed with a 
computer program, and the levels were determined 
by comparison with a standard curve. The lower 
sensitivity limit for DA was approximately 0.1 µg/l, 
and for DOPAC it was 0.2 µg/l.
Histology. After completion of the experimental, 
the rats were anesthetized with sodium pentobarbital 
and perfused transaortally with 0.9% NaCl for 5 min 
followed by 4% paraformaldehyde for 10 min. The 
brains were removed, placed in 4% paraformaldehyde 
for at least 6 h, and immersed in 30% v/v sucrose 
until they sank completely. Coronal 40­µm­thick 
sections were cut with a cryostat, and the placement 
of the cannula tip was confirmed by microscopic 
examination. Only animals with correctly placed 
probes were included in the statistical analyses.
Statistical Analysis.  Microdialysis and CPP 
numerical data among the experiment (HP and LP) 
and control groups were statistically analyzed using 
one­way ANOVA followed by post­hoc analysis by 
means of the Fisher’s protected least significant 
difference (PLSD) test. Differences with P < 0.05 were 
considered significant.
RESULTS
Changes in the Chronic Heroin- or Saline-
Influenced CPP. The baseline CPP values (Pre) in the 
three groups were comparable (P = 0.94). A 7­day­
long heroin treatment significantly increased the time 
spent in the heroin­paired side (M­CPP), compared 
with that in the control group (P < 0.01, P < 0.05). 
The M­CPP of the HP group was significantly greater 
than that in the LP group (P < 0.01) (Fig. 1). 
Effects of Heroin on DA and DOPAC in the 
AcbSh. One­way ANOVA was conducted with respect 
to changes in the microdialysis data in different 
time points among the HP, LP, and saline control 
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(SC) groups. Compared with the SC group, the 
concentrations of extracellular DA (Fig. 2A ) and 
DOPAC (B ) in the AcbSh were significantly higher 
at 30 min after the last heroin injection (P < 0.001). 
However, the DA concentrations in both HP and LP 
groups decreased sharply on days 1 and 3 after the 
last injection, while these indices were significantly 
lower than in the control group (P < 0.05, P < 0.01). 
The DA concentrations in heroin­treated rats recovered 
gradually in a week after the last injection. On days 
7 and 14, those were still lower, but there was no 
significant difference compared to that in the SC group. 
Compared with the LP group, the DA concentration in 
the AcbSh of the HP group was significantly higher 
after the last injection (P < 0.01), and the two groups 
demonstrated no significant differences with respect 
to withdrawal (A). 
Although the DOPAC level decreased significantly 
after withdrawal, this index in the AcbSh of HP rats was 
significantly higher than that in LP­ and SC­group rats 
at all five time points (P < 0.05, P < 0.01). At the same 
time, there were no significant differences in the DOPAC 
concentration between the LP­ and SC­groups at many 
time points within 14 days of withdrawal (Fig. 2B).
Comparison of the DOPAC/DA Ratios in the 
AcbSh. The DOPAC/DA value is believed to be an 
important indicator of the DA update rate. One­way 
ANOVA was conducted among the experimental (HP 
and LP) groups and SC group with respect to this ratio 
at different time points. The DOPAC/DA ratios in the 
AcbSh in both HP and LP groups were significantly 
higher 30 min after the last heroin injection compared 
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F i g. 1. Differences in the conditioned place preference (CPP) 
influenced by chronic heroin or saline treatment. Vertical scale) 
Actual total times (sec) spent at the non­preferred side(s). Pre are 
values before the treatments, CCP are those after heroin treatment 
in the respective group, and M­CCP are differences between the 
baseline and test CCP values. HP, LP, and SC are the high­preference 
group (n = 12), low­preference group (n = 12), and saline control 
group (n = 8), respectively. *P < 0.05,**P < 0.01 in the comparisons 
shown. Data in this and subsequent Figures are presented as means 
± s.e.m.
Р и с. 1. Розбіжності умовнорефлекторної преференції місця, 
зумовлені хронічними введеннями героїну або фізіологічного 
розчину.
F i g. 2. Dynamics of changes in the concentrations of extracellular DA (A) and DOPAC (B) in the nucl. accumbens shell (AcbSh) measured 
in different experimental groups by in vivo microdialysis at different time points (30 min, days 1, 3, 7, and 14) after the last heroin injection. 
In HP, LP, and SC groups, n = 8, n = 7, and n = 6, respectively. ***P < 0.001 (comparison by one­way ANOVA). Other designations are 
similar to those in Fig. 1.
Р и с. 2. Динаміка змін зовнішньоклітинних концентрацій дофаміну та дигідроксифенілоцтової кислоти в шкаралупі nucl. accumbens 
(AcbSh), оцінюваних у різні моменти часу за допомогою мікродіалізу in vivo.
HP HPLP LPSC SC
30 min 30 minday 1 day 13 37 714 14
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with that in the SC group and then gradually decreased 
after withdrawal. However, the LP group demonstrated 
no significant difference from the SC group 3 days 
after the last injection. At all five monitored time 
points, the HP rats had, however, significantly higher 
DOPAC/DA ratios than those in LP­ and SC­group rats 
(P < 0.05, P < 0.01, P < 0.001) (Fig. 3).
DISCUSSION
In this study, all rats of the same strain and kept in 
the same environment were treated by chronic heroin 
conditioning training. Some rats stayed much longer 
at the drug side, while this index for other rats did 
not increase considerably (and even decrease). 
The dissimilar tendency of the CPP development in 
these animals may be considered related to different 
vulnerabilities to drug addiction. 
Activation of the limbic DA system is an important 
mechanism of opioid psychological dependence. 
Previous studies also showed that the rewarding effects 
of opioids were parallel with the DA concentration 
increase in the limbic system. The results showed 
that, after chronic heroin treatment in both HP and 
LP groups, the concentrations of extracellular DA and 
DOPAC in the AcbSh were significantly higher than 
those in the control group, indicating that heroin can 
induce DA release and its increased metabolism. This is 
consistent with previous studies related to opioids [22�.
We also found that the examined DA concentration 
significantly decreased after withdrawal, and on 
days 1 and 3 of withdrawal it was even significantly 
lower than that in the control group. Then this index 
gradually recovered after a week, which is consistent 
with the majority of observations [23�. This suggests 
that the DA concentration gradually decreased after 
withdrawal because of the lack of sustained heroin 
stimulation. At the same time, the sustained high­
concentration state of DA within the addiction phase 
led to down­regulation of the postsynaptic membrane 
DA receptor function by a negative feedback 
mechanism. Then, the low functional state of the DA 
central system could be the neurobiological basis of 
the withdrawal symptoms [1]. 
The DOPAC concentration and DOPAC/DA ratio are 
believed to be effective indicators of activity of the DA 
system or DA update rate. We found that, within the 
addiction period, the DOPAC/DA ratios in the HP and 
LP groups were significantly higher than that in the 
control (SC) group, indicating that the DA update rate 
in the AcbSh is significantly higher. After withdrawal, 
the DOPAC level and DOPAC/DA ratio in rats with 
different addiction vulnerabilities demonstrated clear 
differentiation. The DOPAC/DA index in the HP group 
was significantly higher than that in the control and LP 
groups, and so did the DOPAC level, while the latter 
after withdrawal and the DOPAC/DA ratio after 3 days 
of withdrawal in the LP group showed no significant 
difference from the control (SC) group, which 
suggested that rats with high addiction vulnerability 
had a higher DA reactivity to drugs compared with 
low­vulnerability rats. However, a higher DA update 
rate also leads to stronger craving for heroin. Results 
of other studies on the addiction susceptibility in rats 
to alcohol [15], cocaine [14, 18], amphetamine [13], 
and morphine [16] also agree with this finding.
The findings in our study indicate that the difference 
in susceptibility to heroin addiction in rats depends 
on the responsiveness of the DA system to drug 
exposure. Heroin HP rats have a higher DA system 
responsiveness in the AcbSh, which is possibly one 
of the neurobiochemical factors responsible for the 
heroin vulnerability and is an individual marker of the 
respective differences. 
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Р е з ю м е
Результати попередніх досліджень продемонстрували, 
що змінений під впливом фармакологічних агентів 
рівень дофаміну (DA) в шкаралупі nucl. accumbens 
(AcbSh) є визначальним фактором для вразливості до 
героїнової аддукції у лінійних мишей. Ми досліджували 
можливу роль реактивності DA­ергічної системи AcbSh 
у вразливості умовнорефлекторної преференції місця 
(УРПМ) щодо героїну у щурів лінї Спрейг–Доулі. 
Щури були рандомізовано поділені на «героїнову» та 
контрольну групи. Щури першої з них потім додатково 
поділи на дві групи відповідно до інтенсивності змін 
УРПМ під впливом героїну – тварин з високою та низькою 
«героїновою» преференцією (HP та LP). Рівні DA та 
дигідроксифенілоцтової кислоти (DOPAC) у позаклітинному 
просторі AcbSh оцінювали в динаміці за допомогою 
мікродіалізу in vivo. Позаклітинні концентрації DА та 
DOPAC у «героїнових» групах через 30 хв після останньої 
ін’єкції були істотно вищими, ніж у контролі, але рівень DA 
у тварин цих груп швидко знижувався і на першу та третю 
добу ставав нижчим порівняно з контролем. Тварини групи 
HP порівняно зі щурами групи LP демонстрували вищі 
значення індукованого героїном збільшення концентрації 
DA через 30 хв після останньої ін’єкції героїну та вищі 
рівень DOPAC і відношення DOPAC/DA через 14 діб після 
такої ін’єкції. Подібні результати дозволяють вважати, що 
різниці в реактивності DA­ергічної системи в AcbSh можуть 
визначати індивідуальні відмінності вразливості щодо 
героїнової залежності. 
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